D-0862-2022 Class III Terminated

Recalled by Fagron, Inc — Saint Paul, MN

FDA drug recall D-0862-2022 was initiated by Fagron, Inc on Mar 4, 2022 and is designated Class III. Reason for recall: Subpotent Drug The recall status is terminated (terminated Jul 14, 2024). Affected quantity: 58 containers.

Recall details

Product Type
Drugs
Report Date
May 18, 2022
Initiation Date
Mar 4, 2022
Termination Date
Jul 14, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
58 containers

Product description

Nandrolone Decanoate, USP, 100 g per plastic container, Rx Only, For Prescription Compounding, Fagron, Inc. 2400 Pilot Knob Rd., St Paul, MN 55120. NDC 51552-1564-04

Reason for recall

Subpotent Drug

Distribution pattern

Nationwide within the USA

Code information

Lot #: 18H02-U02-044979, 18H02-U02-046141, Exp. Date 10/31/2022; 18L12-U02-050309,18L12-U02-000953, 18L12-U02-A009829, Exp. Date Sep 2023.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0862-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0862-2022. Report a data issue: hello@regdatalab.com.